Franklin Resources Inc Novo Cure LTD Transaction History

Franklin Resources Inc

$378 Billion
Q3 2025

A detailed history of Franklin Resources Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Franklin Resources Inc holds 250,312 shares of NVCR stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250,312

Previous 176,949 41.46%

Holding current value

$2.83 Million

Previous $3.15 Million 2.7%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$10.9 - $18.46 $799,656 - $1.35 Million	73,363 Added 41.46%	250,312 $3.23 Million
Q2 2025 Aug 12, 2025	BUY	$15.37 - $19.4 $61,326 - $77,406	3,990 Added 2.31%	176,949 $3.15 Million
Q1 2025 May 13, 2025	BUY	$17.82 - $30.19 $301,068 - $510,060	16,895 Added 10.83%	172,959 $3.08 Million
Q4 2024 Feb 12, 2025	SELL	$14.54 - $33.41 $360,432 - $828,200	-24,789 Reduced 13.71%	156,064 $4.65 Million
Q3 2024 Nov 12, 2024	BUY	$15.61 - $23.34 $1.95 Million - $2.91 Million	124,793 Added 222.61%	180,853 $2.83 Million

Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $5,382 - $10,942	-455 Reduced 0.81%	56,060 $960,000
Q1 2024 May 13, 2024	BUY	$12.42 - $17.29 $27,572 - $38,383	2,220 Added 4.09%	56,515 $883,000
Q4 2023 Feb 09, 2024	BUY	$11.13 - $15.78 $604,303 - $856,775	54,295 New	54,295 $810,000
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $43,634 - $89,358	1,083 Added 18.61%	6,902 $286,000
Q1 2023 May 12, 2023	SELL	$56.44 - $118.81 $78,451 - $165,145	-1,390 Reduced 19.28%	5,819 $349,000
Q4 2022 Feb 10, 2023	BUY	$63.98 - $85.37 $58,157 - $77,601	909 Added 14.43%	7,209 $528,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $77,168 - $101,661	1,135 Added 21.97%	6,300 $478,000
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $17,659 - $28,048	312 Added 6.43%	5,165 $360,000
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $51,187 - $71,926	851 Added 21.26%	4,853 $402,000
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $41,369 - $67,216	-551 Reduced 12.1%	4,002 $301,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $83,410 - $139,686	-718 Reduced 13.62%	4,553 $528,000
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $500,996 - $866,678	-3,842 Reduced 42.16%	5,271 $1.17 Million
Q1 2021 May 13, 2021	SELL	$124.11 - $190.17 $11.7 Million - $18 Million	-94,496 Reduced 91.2%	9,113 $1.21 Million
Q4 2020 Feb 10, 2021	BUY	$112.16 - $174.14 $11.4 Million - $17.7 Million	101,504 Added 4822.04%	103,609 $17.9 Million
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $122,195 - $234,307	2,105 New	2,105 $234,000

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

74.5M

Call Options Held

1.26M

Put Options Held

247K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Novo Cure LTD Transaction History